Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
10.88
-0.09 (-0.78%)
Nov 21, 2024, 4:00 PM EST - Market closed

Artiva Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
264-----
Enterprise Value
135-----
Debt / Equity Ratio
0.070.310.260.010.13-1.97
Asset Turnover
-0.280.030.02--
Quick Ratio
11.146.454.028.364.411.99
Current Ratio
11.336.534.088.414.532.08
Return on Equity (ROE)
--44.15%-57.84%-99.72%-286.85%-
Return on Assets (ROA)
--16.10%-24.68%-33.44%-67.03%-
Return on Capital (ROIC)
--23.03%-33.32%-45.02%-101.60%-
Buyback Yield / Dilution
-589.85%-4.70%-11.80%-8.60%-3.59%-
Total Shareholder Return
-589.85%-4.70%-11.80%-8.60%-3.59%-
Source: S&P Capital IQ. Standard template. Financial Sources.